Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$595.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 16 most recent Form 4 transactions.
| 18,421 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Sep 15 | TRVI | Trevi Therapeutics, Inc. | SSELL◷ | 100 | $15.88 | $1.6K | -1.6% | Open the original filing on SEC.gov |
| Sep 15 | TRVI | Trevi Therapeutics, Inc. | SSELL◷ | 20,952 | $15.09 | $316.2K | -76.5% | Open the original filing on SEC.gov |
| Sep 15 | TRVI | Trevi Therapeutics, Inc. | MEXER◷ | 21,052 | $3.33 | $70.1K | +331.5% | Open the original filing on SEC.gov |
| Sep 15 | TRVI | Trevi Therapeutics, Inc. | SSELL◷ | 100 | $15.88 | $1.6K | -1.6% | Open the original filing on SEC.gov |
| Sep 15 | TRVI | Trevi Therapeutics, Inc. | SSELL◷ | 18,321 | $15.09 | $276.5K | -74.0% | Open the original filing on SEC.gov |
| Sep 15 | TRVI | Trevi Therapeutics, Inc. | MEXER◷ | 18,421 | $3.04 | $56K | +290.1% | Open the original filing on SEC.gov |
| Jun 16 | ENGN | enGene Therapeutics Inc. | AGRANT◆ | 31,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3 | TRVI | Trevi Therapeutics, Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 2 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 29,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | BHVN | Biohaven Ltd. | AGRANT◆ | 68,693 | — | — | — | Open the original filing on SEC.gov |
| Jul 8, 2025 | ENGN | enGene Therapeutics Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 29,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 11, 2025 | TRVI | Trevi Therapeutics, Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| May 5, 2025 | BHVN | Biohaven Ltd. | AGRANT◆ | 31,716 | — | — | — | Open the original filing on SEC.gov |